![Triptorelin (Prostazar SR) 22.5mg/vial Powder for suspension for injection - Taj Generics Pharmaceuticals | Taj Pharma Triptorelin (Prostazar SR) 22.5mg/vial Powder for suspension for injection - Taj Generics Pharmaceuticals | Taj Pharma](https://tajgenerics.com/wp-content/uploads/cache/images/Triptorelin-Injection-22-5mg-Taj-Pharma-Mumbai/Triptorelin-Injection-22-5mg-Taj-Pharma-Mumbai-4171713090.jpg)
Triptorelin (Prostazar SR) 22.5mg/vial Powder for suspension for injection - Taj Generics Pharmaceuticals | Taj Pharma
![PDF) A prospective, single-centre, single-arm, open label study of the long term use of a gonadotropin releasing hormone agonist (Triptorelin SR, 11.25 mg) in combination with Tibolone add-back therapy in the management PDF) A prospective, single-centre, single-arm, open label study of the long term use of a gonadotropin releasing hormone agonist (Triptorelin SR, 11.25 mg) in combination with Tibolone add-back therapy in the management](https://i1.rgstatic.net/publication/340632535_A_prospective_single-centre_single-arm_open_label_study_of_the_long_term_use_of_a_gonadotropin_releasing_hormone_agonist_Triptorelin_SR_1125_mg_in_combination_with_Tibolone_add-back_therapy_in_the_man/links/5e98f79a299bf13079a1d40c/largepreview.png)
PDF) A prospective, single-centre, single-arm, open label study of the long term use of a gonadotropin releasing hormone agonist (Triptorelin SR, 11.25 mg) in combination with Tibolone add-back therapy in the management
![Significant adverse reactions to long-acting gonadotropin-releasing hormone agonists for the treatment of central precocious puberty and early onset puberty. - Abstract - Europe PMC Significant adverse reactions to long-acting gonadotropin-releasing hormone agonists for the treatment of central precocious puberty and early onset puberty. - Abstract - Europe PMC](https://europepmc.org/articles/PMC4208261/bin/apem-19-135-i002.jpg)
Significant adverse reactions to long-acting gonadotropin-releasing hormone agonists for the treatment of central precocious puberty and early onset puberty. - Abstract - Europe PMC
![Dr Reddy's Laboratories Ltd Triptorelin (Pamorelin LA 11.25mg Powder For Injection) at Rs 15034/vial in Surat Dr Reddy's Laboratories Ltd Triptorelin (Pamorelin LA 11.25mg Powder For Injection) at Rs 15034/vial in Surat](http://5.imimg.com/data5/SELLER/Default/2023/1/SB/KF/UW/9256186/triptorelin-pamorelin-la-11-25mg-powder-for-injection-.png)
Dr Reddy's Laboratories Ltd Triptorelin (Pamorelin LA 11.25mg Powder For Injection) at Rs 15034/vial in Surat
![Effects of Three Month Treatment with Triptorelin on Pain Symptoms of Patients with Endometriosis | Semantic Scholar Effects of Three Month Treatment with Triptorelin on Pain Symptoms of Patients with Endometriosis | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/fc03d1f647bbdf55649f0a55c5574e43dd45adaa/3-Table2-1.png)
Effects of Three Month Treatment with Triptorelin on Pain Symptoms of Patients with Endometriosis | Semantic Scholar
![Ferring Pharmaceuticals Decapeptyl -Triptorelin Injection, Packaging: 1 ml In 1 Vial at Rs 362/vial in Ambala Ferring Pharmaceuticals Decapeptyl -Triptorelin Injection, Packaging: 1 ml In 1 Vial at Rs 362/vial in Ambala](http://5.imimg.com/data5/SELLER/Default/2023/6/317500300/PK/AJ/GE/66751685/decapeptyl-triptorelin-injection.jpg)
Ferring Pharmaceuticals Decapeptyl -Triptorelin Injection, Packaging: 1 ml In 1 Vial at Rs 362/vial in Ambala
![Prolonged pituitary down-regulation with full-dose of gonadotropin-releasing hormone agonist in different menstrual cycles: a retrospective cohort study [PeerJ] Prolonged pituitary down-regulation with full-dose of gonadotropin-releasing hormone agonist in different menstrual cycles: a retrospective cohort study [PeerJ]](https://dfzljdn9uc3pi.cloudfront.net/2019/6837/1/fig-3-full.png)
Prolonged pituitary down-regulation with full-dose of gonadotropin-releasing hormone agonist in different menstrual cycles: a retrospective cohort study [PeerJ]
![Frontiers | Leuprolide and triptorelin treatment in children with idiopathic central precocious puberty: an efficacy/tolerability comparison study Frontiers | Leuprolide and triptorelin treatment in children with idiopathic central precocious puberty: an efficacy/tolerability comparison study](https://www.frontiersin.org/files/Articles/1170025/fped-11-1170025-HTML/image_m/fped-11-1170025-t001.jpg)
Frontiers | Leuprolide and triptorelin treatment in children with idiopathic central precocious puberty: an efficacy/tolerability comparison study
![Effects of Long-Term Gonadotropin-Releasing Hormone Analog Treatment on Growth, Growth Hormone (GH) Secretion, GH Receptors, and GH-Binding Protein in the Rat | Pediatric Research Effects of Long-Term Gonadotropin-Releasing Hormone Analog Treatment on Growth, Growth Hormone (GH) Secretion, GH Receptors, and GH-Binding Protein in the Rat | Pediatric Research](https://media.springernature.com/m685/springer-static/image/art%3A10.1203%2F00006450-199801000-00017/MediaObjects/41390_1998_Article_BFpr199817_Fig5_HTML.jpg)
Effects of Long-Term Gonadotropin-Releasing Hormone Analog Treatment on Growth, Growth Hormone (GH) Secretion, GH Receptors, and GH-Binding Protein in the Rat | Pediatric Research
![Children | Free Full-Text | Use of the Subcutaneous Triptorelin Stimulation Test for Diagnosis of Central Precocious Puberty Children | Free Full-Text | Use of the Subcutaneous Triptorelin Stimulation Test for Diagnosis of Central Precocious Puberty](https://www.mdpi.com/children/children-10-01830/article_deploy/html/images/children-10-01830-g001b.png)
Children | Free Full-Text | Use of the Subcutaneous Triptorelin Stimulation Test for Diagnosis of Central Precocious Puberty
![Assessment of Two Formulations of Triptorelin in Chinese Patients with Endometriosis: A Phase 3, Randomized Controlled Trial | Advances in Therapy Assessment of Two Formulations of Triptorelin in Chinese Patients with Endometriosis: A Phase 3, Randomized Controlled Trial | Advances in Therapy](https://media.springernature.com/m685/springer-static/image/art%3A10.1007%2Fs12325-022-02264-5/MediaObjects/12325_2022_2264_Fig1_HTML.png)
Assessment of Two Formulations of Triptorelin in Chinese Patients with Endometriosis: A Phase 3, Randomized Controlled Trial | Advances in Therapy
![Children | Free Full-Text | Use of the Subcutaneous Triptorelin Stimulation Test for Diagnosis of Central Precocious Puberty Children | Free Full-Text | Use of the Subcutaneous Triptorelin Stimulation Test for Diagnosis of Central Precocious Puberty](https://www.mdpi.com/children/children-10-01830/article_deploy/html/images/children-10-01830-g001a.png)